News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,412 Results
Type
Article (5013)
Company Profile (17)
Press Release (220382)
Section
Business (82201)
Career Advice (461)
Deals (15042)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120104)
Policy (7502)
Tag
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14777)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3695)
Artificial intelligence (43)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (10)
Brain cancer (7)
Breast cancer (48)
Cancer (456)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (33)
Cell therapy (107)
Cervical cancer (2)
Clinical research (16040)
Collaboration (172)
Compensation (172)
Complete response letters (2)
COVID-19 (301)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (526)
Depression (7)
Diabetes (43)
Diagnostics (2045)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40912)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37832)
Executive appointments (315)
FDA (3940)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (109)
Government (412)
Guidances (21)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7824)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (32)
Management (10)
Manufacturing (50)
MASH (29)
Medical device (3862)
Medtech (3863)
Mergers & acquisitions (7426)
Metabolic disorders (125)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (345)
NextGen: Class of 2025 (1674)
Non-profit (727)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (14)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (33)
Peanut (5)
People (24610)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4783)
Phase II (6964)
Phase III (5551)
Pipeline (577)
Policy (9)
Postmarket research (625)
Preclinical (1873)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1874)
Recruiting (8)
Regulatory (5126)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1009)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (37)
Venture capitalists (2)
Weight loss (22)
Women's health (1)
Date
Today (59)
Last 7 days (237)
Last 30 days (712)
Last 365 days (9914)
2025 (3223)
2024 (11029)
2023 (13194)
2022 (18661)
2021 (19680)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9158)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11462)
Australia (1611)
California (1993)
Canada (716)
China (73)
Colorado (84)
Connecticut (97)
Delaware (30)
Europe (24543)
Florida (287)
Georgia (34)
Idaho (23)
Illinois (117)
India (7)
Indiana (64)
Iowa (2)
Japan (75)
Kansas (24)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1596)
Michigan (86)
Minnesota (141)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (576)
New Mexico (5)
New York (480)
North Carolina (332)
North Dakota (3)
Northern California (950)
Ohio (60)
Oklahoma (5)
Oregon (4)
Pennsylvania (353)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (6)
Southern California (719)
Tennessee (40)
Texas (230)
United States (7208)
Utah (61)
Virginia (46)
Washington D.C. (9)
Washington State (176)
West Virginia (2)
Wisconsin (25)
225,412 Results for "heska corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Heska Corporation Reports First Quarter 2023 Results
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results for its first quarter ended March 31, 2023.
May 5, 2023
·
10 min read
Business
Heska Corporation Reports Fourth Quarter and Full Year 2022 Results
Heska Corporation reported financial results in two segments for its fourth quarter and full year ended December 31, 2022.
February 28, 2023
·
27 min read
Deals
Heska Corporation Completes Acquisition of LightDeck Diagnostics
Heska Corporation announced the completion of acquisition of 100% of the shares of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics, a pioneer in planar waveguide fluorescence immunoassay diagnostics with strong manufacturing capabilities and research and development expertise.
January 3, 2023
·
3 min read
BioMidwest
Heska to Present at Three Upcoming Institutional Investor Conferences
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska’s management team will present at three institutional investor conferences in March 2023.
February 23, 2023
·
2 min read
BioMidwest
Heska Announces Annual Meeting of Stockholders on May 3, 2023
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announces its 2023 Annual Meeting of Stockholders.
April 21, 2023
·
2 min read
Business
Heska Corporation Reports Third Quarter 2022 Results
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments for its third quarter ended September 30, 2022.
November 8, 2022
·
12 min read
Business
Heska Corporation Reports Second Quarter 2022 Results
Heska Corporation (NASDAQ: HSKA; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments ( North America and International) for its second quarter ended June 30, 2022.
August 8, 2022
·
22 min read
Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference
Heska Corporation announced that members of Heska’s management team will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
December 23, 2022
·
1 min read
BioMidwest
Volition’s Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation
VolitionRx Limited, a multi-national epigenetics company, announces its Nu.Q® Vet Cancer Test is now available for pre-order to veterinarians at the point-of-care through Heska Corporation .
February 16, 2023
·
8 min read
Business
Heska Corporation Reports First Quarter 2022 Results
Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments for its first quarter ended March 31, 2022.
May 9, 2022
·
17 min read
1 of 22,542
Next
